Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioRestorative Therapies, Inc.

1.76
+0.04002.33%
Volume:32.69K
Turnover:55.67K
Market Cap:13.21M
PE:-1.52
High:1.79
Open:1.70
Low:1.67
Close:1.72
Loading ...

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities

GlobeNewswire
·
15 Apr

BRIEF-BioRestorative confirms no material impact from reciprocal tariffs

Reuters
·
10 Apr

BioRestorative Confirms No Material Impact From Reciprocal Tariffs; All Brtx-100 Production & Manufacturing Performed in the United States

THOMSON REUTERS
·
10 Apr

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States

GlobeNewswire
·
10 Apr

BioRestorative Therapies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
29 Mar

BioRestorative Therapies Q4 2024 GAAP EPS $(0.20) Beats $(0.28) Estimate, Sales $43.300K Miss $475.000K Estimate

Benzinga
·
28 Mar

BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update

GlobeNewswire
·
28 Mar

BioRestorative Therapies Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
26 Mar

BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025

THOMSON REUTERS
·
21 Mar

BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025

GlobeNewswire
·
21 Mar

Analysts Are Bullish on Top Healthcare Stocks: BioRestorative Therapies (BRTX), Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
02 Mar

BioRestorative Therapies Says FDA Clears BRTX-100 Trial in Chronic Cervical Discogenic Pain

MT Newswires Live
·
27 Feb

BioRestorative announces FDA clearance of IND for Phase 2 BRTX-100 trial

TIPRANKS
·
27 Feb

BioRestorative Announces FDA Clearance of Ind for Phase 2 Trial of Brtx-100 in Chronic Cervical Discogenic Pain

THOMSON REUTERS
·
27 Feb

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain

GlobeNewswire
·
27 Feb

BioRestorative Announces Updated Time for February 27TH Webcasted Conference Call to Discuss Clinical Pipeline Update

THOMSON REUTERS
·
27 Feb

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update

GlobeNewswire
·
27 Feb

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline

THOMSON REUTERS
·
25 Feb

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline

GlobeNewswire
·
25 Feb

BioRestorative Therapies announces new data on BRTX-100 presented at ORS 2025

TIPRANKS
·
10 Feb